NUVB
NYSE · Pharmaceuticals
Nuvation Bio Inc
$4.49
+0.04 (+0.90%)
Open$4.45
Previous Close$4.45
Day High$4.53
Day Low$4.38
52W High$9.75
52W Low$1.57
Volume—
Avg Volume5.56M
Market Cap1.68B
P/E Ratio—
EPS$-0.60
SectorPharmaceuticals
Analyst Ratings
Strong Buy
17 analysts
Price Target
+862.6% upside
Current
$4.49
$4.49
Target
$43.22
$43.22
$30.63
$43.22 avg
$69.64
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 68.91M | 781.90M | 798.00M |
| Net Income | -224,116,958 | 141.36M | 136.11M |
| Profit Margin | -325.3% | 18.1% | 17.1% |
| EBITDA | -230,700,932 | 195.91M | 227.47M |
| Free Cash Flow | — | 85.45M | 83.04M |
| Rev Growth | — | +23.6% | -6.7% |
| Debt/Equity | 0.68 | 0.84 | 0.71 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $948.45 | -2.72% | 36.1 | 913.24B |
| JNJ | Johnson & Johnson | $221.32 | -0.53% | 26.1 | 548.94B |
| MRK | Merck & Co. Inc. | $111.38 | -0.82% | 31.3 | 279.42B |
| PFE | Pfizer Inc. | $25.68 | -3.02% | 19.3 | 150.09B |
| BMY | Bristol-Myers Squibb Co | $56.16 | -0.16% | 17.0 | 120.08B |
| ZTS | Zoetis Inc | $82.83 | -5.13% | 21.5 | 57.37B |